Limiting Hepatitis C Virus (HCV) Progression in Liver Transplant Recipients Using Sirolimus Based Immunosuppression

被引：0
|
作者：
McKenna, Greg J. [1 ]
Trotter, James [1 ]
Klintmalm, Erik [1 ]
Chinnakotla, Srinath [1 ]
Randall, Henry [1 ]
Onaca, Nicholas [1 ]
Ruiz, Richard [1 ]
Levy, Marlon F. [1 ]
Goldstein, Robert M. [1 ]
Klintmalm, Goran B. [1 ]
机构：
[1] Baylor Reg Transplant Inst, Dallas, TX USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2010年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [1] Limiting Hepatitis C Virus Progression in Liver Transplant Recipients Using Sirolimus-Based Immunosuppression
    McKenna, G. J.
    Trotter, J. F.
    Klintmalm, E.
    Onaca, N.
    Ruiz, R.
    Jennings, L. W.
    Neri, M.
    O'Leary, J. G.
    Davis, G. L.
    Levy, M. F.
    Goldstein, R. M.
    Klintmalm, G. B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (11) : 2379 - 2387
  • [2] IMPACT OF SIROLIMUS BASED IMMUNOSUPPRESSION ON FIBROSIS PROGRESSION IN HCV LIVER TRANSPLANT RECIPIENTS
    Nandy, Nina
    Rogers, Christin
    Nasser, Imad
    Challies, Tracy L.
    Karp, Seth
    Johnson, Scott
    Hanto, Douglas W.
    Curry, Michael P.
    HEPATOLOGY, 2010, 52 (04) : 395A - 395A
  • [3] THE IMPACT OF SIROLIMUS ON HEPATITIS C PROGRESSION IN LIVER TRANSPLANT RECIPIENTS
    Klintmalm, Erik
    McKenna, Greg J.
    Trotter, James
    Sanchez, Edmund Q.
    Chinnakotla, Srinath
    Randall, Henry B.
    Ruiz, Richard
    Onaca, Nicholas
    Levy, Marlon F.
    Goldstein, Robert M.
    Klintmalm, Goran
    HEPATOLOGY, 2009, 50 (04) : 559A - 560A
  • [4] Limiting HCV Progression in Transplant Recipients through Conversion to Sirolimus Based lmmunosuppression
    McKenna, Greg J.
    Trotter, James
    Klintmalm, Erik
    Chinnakotla, Srinath
    Randall, Henry B.
    Ruiz, Richard
    Onaca, Nicholas
    Levy, Marlon F.
    Goldstein, Robert M.
    Klintmalm, Goran B.
    LIVER TRANSPLANTATION, 2010, 16 (06) : S118 - S119
  • [5] Impact of Conversion to Sirolimus-Based Immunosuppression on Fibrosis Progression in HCV plus Liver Transplant Recipients.
    Stevens, D. R.
    Curry, M. P.
    Nandy, N.
    Nasser, I.
    Challies, T.
    Rogers, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 46 - 46
  • [6] End of the Line for Sirolimus in Liver Transplant Recipients With Hepatitis C Virus?
    De Simone, Paolo
    Saliba, Faouzi
    Fischer, Lutz
    LIVER TRANSPLANTATION, 2013, 19 (02) : 236 - 237
  • [7] Induction immunosuppression in hepatitis C virus-infected liver transplant recipients
    Lucey, MR
    LIVER TRANSPLANTATION, 2002, 8 (10) : S44 - S46
  • [8] Impact of Sirolimus Duration on Hepatitis C Related Fibrosis Progression in Liver Transplant Recipients
    Kim, M.
    Curry, M. P.
    Rogers, C. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (05) : 1356 - 1357
  • [9] Immunosuppression Withdrawal in Liver Transplant Recipients on Sirolimus
    Levitsky, Josh
    Mathew, James M.
    Miller, Joshua
    Heinrichs, Jessica
    Huang, Xumei
    Abecassis, Michael M.
    HEPATOLOGY, 2016, 64 : 1A - 1A
  • [10] Immunosuppression Withdrawal in Liver Transplant Recipients on Sirolimus
    Levitsky, Josh
    Burrell, Bryna E.
    Kanaparthi, Sai
    Turka, Laurence A.
    Kurian, Sunil
    Sanchez-Fueyo, Alberto
    Lozano, Juan J.
    Demetris, Anthony
    Lesniak, Andrew
    Kirk, Allan D.
    Stempora, Linda
    Yang, Guang-Yu
    Mathew, James M.
    HEPATOLOGY, 2020, 72 (02) : 569 - 583
12345